Today: 22 January 2026
Subscribe
Browse Category

ASX:PLS News 18 January 2026 - 22 January 2026

ASX:PLS share price tops A$5 as China lithium futures bounce; traders watch Jan 30 update

ASX:PLS share price tops A$5 as China lithium futures bounce; traders watch Jan 30 update

Sydney, Jan 22, 2026, 17:02 AEDT — Market closed PLS Group Limited shares ended Thursday above A$5, rising 1.8% to close at A$5.04 after moving between A$4.97 and A$5.07 during the session. Roughly 19.5 million shares were traded. The stock has gained around 17% year-to-date on daily closes. (StockAnalysis) Traders are zeroing in on China’s lithium price moves as a…
22 January 2026
·····
PLS Group (ASX:PLS) share price jumps after lithium bid returns; what to watch next

PLS Group (ASX:PLS) share price jumps after lithium bid returns; what to watch next

Sydney, Jan 21, 2026, 17:25 AEDT — After-hours PLS Group Limited shares climbed 4.4% to A$4.95 in Sydney on Wednesday, recovering from early dips as buyers stepped back into lithium-related stocks. The price fluctuated between A$4.77 and A$4.95, compared to a previous close of A$4.74. (Intelligent Investor) This move is significant since PLS ranks as the ASX’s largest pure-play lithium…
21 January 2026
·····
PLS Group share price: AustralianSuper trims stake, setting up a Monday test for ASX:PLS

PLS Group share price: AustralianSuper trims stake, setting up a Monday test for ASX:PLS

Sydney, Jan 18, 2026, 17:11 AEDT — The market has closed. PLS Group Ltd kicks off the week with a new big-holder update showing AustralianSuper has trimmed its stake in the lithium miner. On Friday, the shares closed 3.1% lower at A$4.68, bouncing between A$4.60 and A$4.89 during the session. (Yahoo Finance) The filing came after the market closed, posted…
18 January 2026
····

Stock Market Today

  • DaVita (DVA) Share Price Down 36.9% in One Year But DCF Model Suggests Undervaluation
    January 22, 2026, 4:29 AM EST. DaVita (DVA) shares have fallen 36.9% over the past year to $106.30, underperforming peers amid sector and policy uncertainties in healthcare. The stock gained 2.3% in the last week but lost 8.8% over the past month. Despite short-term declines, Simply Wall St's valuation checks rate DaVita highly, with a 6 out of 6 score. A discounted cash flow (DCF) analysis estimates DaVita's intrinsic value at $322.62 per share, implying the stock is 67.1% undervalued based on projected future cash flows. Investors are weighing if current prices reflect these fundamentals or if market sentiment driven by healthcare sector volatility prevails.
Go toTop